(Q27270940)

VX-661 (English)

14 October 2016

C₂₆H₂₇F₃N₂O₆

1 reference

VX-661 (English)

14 October 2016

CC(C)(CO)C1=CC2=CC(=C(C=C2N1CC(CO)O)F)NC(=O)C3(CC3)C4=CC5=C(C=C4)OC(O5)(F)F

1 reference

VX-661 (English)

14 October 2016

CC(C)(CO)C1=CC2=CC(=C(C=C2N1C[C@H](CO)O)F)NC(=O)C3(CC3)C4=CC5=C(C=C4)OC(O5)(F)F

1 reference

InChI=1S/C26H27F3N2O6/c1-24(2,13-33)22-8-14-7-18(17(27)10-19(14)31(22)11-16(34)12-32)30-23(35)25(5-6-25)15-3-4-20-21(9-15)37-26(28,29)36-20/h3-4,7-10,16,32-34H,5-6,11-13H2,1-2H3,(H,30,35)/t16-/m1/s1

English

title

VX-661 (English)

retrieved

14 October 2016

Identifiers

InChI

1 reference

VX-661 (English)

14 October 2016

1 reference

Global Substance Registration System

VX-661 (English)

14 October 2016

2 references

UNII

8RW88Y506K

tezacaftor (English)

14 October 2016

https://commonchemistry.cas.org/detail?cas_rn=1152311-62-0

10 April 2021

1 reference

Tezacaftor (English)

14 October 2016

2 references

English

title

VX-661 (English)

retrieved

14 October 2016

1 reference

TEZACAFTOR (English)

14 October 2016

2 references

inferred from InChIKey

SCHEMBL322362

2 references

based on heuristic

inferred from InChIKey

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

1 reference

2 references

DSSTOX compound identifier

DTXCID00623819

0 references

Guide to Pharmacology Ligand ID

10199

1 reference

stated in

IUPHAR/BPS Guide to PHARMACOLOGY

5 February 2021

0 references

1 reference

Human Metabolome Database ID

HMDB0304895

2 references

based on heuristic

inferred from InChIKey

Global Substance Registration System

UNII

8RW88Y506K

2 references

stated in

UNII

8RW88Y506K

English

title

tezacaftor (English)

retrieved

14 October 2016